Prostate News and Research

RSS

Cancer death rates fall among African Americans - survival rates still low

While death rates from cancer continue to drop among African Americans, the group continues to be diagnosed at more advanced stages and have lower survival rates at each stage of diagnosis compared to whites for most cancer sites.

20 Feb 2009

Cancer survivors more likely to be unemployed

An analysis of previous studies finds an association between being a cancer survivor and being unemployed, compared to healthy individuals, especially for survivors of breast and gastrointestinal cancers, according to an article in the February 18 issue of JAMA, the Journal of the American Medical Association.

18 Feb 2009

Discovery of new biomarker for fatal prostate cancer

New research findings out of Wake Forest University School of Medicine and the University of Wisconsin may help provide some direction for men diagnosed with prostate cancer about whether their cancer is likely to be life-threatening.

16 Feb 2009

Discovery of new prostate cancer marker

Howard Hughes Medical Institute researchers have identified a new biological marker present in the urine of patients with prostate cancer that indicates whether the cancer is progressing and spreading.

15 Feb 2009

Discovery of metabolite linked to aggressive prostate cancer

Researchers from the University of Michigan Comprehensive Cancer Center have identified a panel of small molecules, or metabolites, that appear to indicate aggressive prostate cancer.

15 Feb 2009

Compound can distinguish between benign tissue and localized and metastatic prostate cancer

Researchers have determined that a molecule produced by the bodys metabolism could be used to differentiate between benign prostate tissue vs. localized and metastatic prostate cancer.

11 Feb 2009

Mentally ill endure lives of loneliness and exclusion

New research from the Australian mental illness charity SANE has revealed that victims of mental illness pay a high price in terms of personal relationships and social contact.

9 Feb 2009

Preventing prostate cancer the complex way

Blocking a specific protein complex prevents the formation of tumors in mice genetically predisposed to develop prostate cancer.

3 Feb 2009

Green tea may counteract anticancer effects of cancer therapy, bortezomib (Velcade)

Green tea products have become regarded as a valuable health supplement, as studies have shown evidence of its benefit against a variety of diseases, including cancer.

3 Feb 2009

Shift workers' body clocks studied to prevent certain cancers

Does shift work predispose you to cancer by altering the body's response to hormones?

2 Feb 2009

Top hospitals have 27 percent lower mortality: Annual HealthGrades study

Medicare patients treated at top-rated hospitals nationwide across the most common Medicare diagnoses and procedures are 27 percent less likely to die, on average, than those admitted to all other hospitals, according to a study released today by HealthGrades, the leading independent healthcare ratings organization.

29 Jan 2009

Masturbation as a young man linked to higher prostate cancer risk

Men who are very sexually active in their twenties and thirties are more likely to develop prostate cancer, especially if they masturbate frequently, according to a study of more than 800 men published in the January issue of BJU International.

27 Jan 2009

Virotherapy treatment kills prostate cancer cells

A new study appearing in The Prostate has found that certain measles virus vaccine strain derivatives, including a strain known as MV-CEA, may prove to be an effective treatment for patients with advanced prostate cancer.

21 Jan 2009

Researchers show how anthracycline class of chemotherapeutics block blood vessel growth, slow cancer spread

Researchers at the Johns Hopkins University School of Medicine have discovered how a whole class of commonly used chemotherapy drugs can block cancer growth.

21 Jan 2009

Potential new biomarker for colon cancer

Cincinnati scientists have identified a new biomarker that could help predict a person's risk of developing colon cancer and how aggressive it may become.

19 Jan 2009

Researchers find novel use for old compound in cancer treatment

The compound, alpha-difluoromethylornithine or DFMO, targets the activity of a specific enzyme and, even in very limited doses, is effective in protecting against the malignancy in animal models.

19 Jan 2009

Cancer survivor needs examined beyond specialized care

According to the National Cancer Policy Board, it is estimated that by the year 2050 there will be more cancer survivors in the United States than those newly diagnosed with the disease.

19 Jan 2009

Algeta completes phase II trial with Alpharadin for treating bone metastases in advanced prostate cancer

Algeta ASA has announced that with the results of the BC1-04 study reported today it has completed its comprehensive phase II clinical program evaluating Alpharadin (radium-223) as a new treatment for bone metastases in patients with hormone-refractory prostate cancer (HRPC).

15 Jan 2009

Advaxis wins European patent case involving Lovaxin-C vaccine

The European Patent Court in Munich, Germany has ruled in favor of Advaxis Incorporated and reversed a patent challenge made by Anza Therapeutics, Inc., formerly Cerus Corp.

15 Jan 2009

Theraputic target for prostate cancer

The report, entitled Cytosolic Phospholipase A2-: A Potential Therapeutic Target for Prostate Cancer, describes the possible role of an enzyme called cPLA2- in prostate cancer and its potential to be a treatment target for prostate cancers that no longer respond to hormone-related therapy.

14 Jan 2009